NEURINOX Project Symposium: Innovation Concepts for Treating Neurodegenerative Disease, Molecular Biotec. Centre,Turin, Italy

The NEURINOX project, www.neurinox.eu coordinated by the University of Geneva, involving several SMEs, internationally renowned research groups and clinical institutions with extensive experience in NADPH oxidases (NOX) research and neurodegenerative diseases collaborate for a common goal: understanding the role of NOX enzymes in neuroinflammation and evaluate their potential as drug targets for the treatment of neurodegenerative diseases.

This five year research project should provide the following main results:
• A better understanding of common mechanisms of brain diseases, and in particular oxidative stress-mediated ND and the link between the different NOX isoforms and neuroinflammation and how their activities control the neuroinflammatory process in ND;
• Novel molecular pathways, genes, SNPs and biomarkers of oxidation correlating with NOX activity, neuroinflammation and ND progression;
• Small molecules validated in NEURINOX using ND animal & in vitro models;
• Validation of NOX as viable targets for the development of therapeutics for ALS and potentially many other neuroinflammatory ND.

This Symposium, which is taking place more than a year before the end of the project, will show the research progress made so far in the project.

For further information on the event and registration (from 1 April), please click on the following link: http://www.neurinox.eu/page/news-and-events.php(opens in new window)